Nalbuphine Versus Tramadol on Post Operative Analgesia in Abdominal Surgery on Pediatric Cancer Patient

Launched by NATIONAL CANCER INSTITUTE, EGYPT · Jul 31, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at two different medicines, nalbuphine and tramadol, to see which one works better for controlling pain after abdominal surgery in children with cancer. The goal is to find out which medicine helps kids feel more comfortable after their operation.

Children between the ages of 3 and 12 who are scheduled for planned abdominal surgery and are generally healthy enough for surgery (according to a common health rating system called ASA I-III) may be able to join the study. Kids whose guardians do not agree, those who are allergic to either medicine, or those who have been taking opioid pain medicines long-term will not be eligible. If a child joins, they will receive either nalbuphine or tramadol after surgery to manage their pain, and the medical team will monitor how well the medicine works and if there are any side effects. This study is currently looking for participants, and families interested in learning more should speak with their doctor.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participants will be children aged 3-12 years
• • American society of anesthesia (ASA) classification I-III.
• • scheduled for elective Abdominal surgery under general anesthesia
• Exclusion Criteria:
• • child guardian refusal.
• • Allergy from Tramal or nalbuphine
• • Patient with previous chronic pain on opioids